Friday, July 10, 2026

Drug profile · INN

bazedoxifene acetate

bazedoxifene acetate (DUAVEE) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bazedoxifene acetate
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

bazedoxifene acetate (DUAVEE) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN bazedoxifene acetate
Brand DUAVEE
Mechanism Estrogen receptor modulator
Target Estrogen receptor
Route ORAL
Formulation TABLET

Mechanism of action

Estrogen receptor modulator

Primary target: Estrogen receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. estradiol Estrogen receptor alpha agonist
  2. estradiol valerate Estrogen receptor alpha agonist
  3. estrogens, conjugated synthetic a Estrogen receptor agonist
  4. estropipate Estrogen receptor alpha agonist
  5. ethinyl estradiol Estrogen receptor alpha agonist
  6. fulvestrant Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is bazedoxifene acetate?

bazedoxifene acetate (DUAVEE) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for bazedoxifene acetate?

DUAVEE is a marketed brand name for bazedoxifene acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bazedoxifene acetate?

bazedoxifene acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.